Structural insights and clinical advances in small-molecule inhibitors targeting TGF-β receptor I

The dysregulation of the transforming growth factor β (TGF-β) signaling pathway plays a critical role in the onset and progression of several diseases, including cancer. Notably, TGF-β has emerged as a significant barrier to effective outcomes in cancer immunotherapies, particularly those using immu...

Full description

Saved in:
Bibliographic Details
Main Authors: Carlota Leonardo-Sousa, Rodrigo Barriga, Helena F. Florindo, Rita C. Acúrcio, Rita C. Guedes
Format: Article
Language:English
Published: Elsevier 2025-03-01
Series:Molecular Therapy: Oncology
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2950329925000141
Tags: Add Tag
No Tags, Be the first to tag this record!